45-minute Program
Effective dates for CE credit: 8/6/2023 – 8/6/2025

Description

People with T2D are at high risk of developing heart failure. This session will provide a comprehensive overview of the mechanism for increased risk and progression to diabetic cardiomyopathy in people with T2D and how to choose blood glucose-lowering medications in people with heart failure. Presenters will review the clinical impact of the heart failure-related results published in the cardiovascular outcomes trials for SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and discuss clinical practice considerations for the management of patients with T2D and chronic heart failure. Finally, attendees will learn key clinical considerations for optimal medication therapy and education for a person with diabetes and heart failure through the presentation of a clinical case.

Learning Outcome

Attendees will apply evidence-based solutions and interventions for equitable healthcare, including comprehensive care for individuals with diabetes and related conditions, addressing behavioral health concerns, advocating for sustainable technology-enabled care, implementing interprofessional team practices, and enhancing clinical care and support in diverse settings.

Activity Type

This recording of a live presentation is a knowledge-based learning activity.

Learning Format

Enduring Material

Intended Audience

This activity is designed for individual or groups of diabetes care and education specialists, including nurses, dietitians, dietetic technicians, pharmacists, pharmacy technicians, nurse practitioners, clinical nurse specialists, physicians, PAs, social workers, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.

Access Period

You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).

Originally presented on: 8/6/2023
Expiration date: 8/6/2025

Faculty

Faculty Disclosures

In accordance with Joint Accreditation criteria and the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, the Association of Diabetes Care & Education Specialists (ADCES) must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.

Joint Accreditation/ACCME also requires that ADCES mitigate any reported conflict and eliminate the potential for bias during the educational activity. The disclosure information is intended to identify any ineligible relationships and allow learners to form their own judgments. However, if you perceive a bias during an activity, please report it on the evaluation.

Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:

Dejan Landup, PharmD: No financial relationships or conflicts of interest
Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP: Abbott: Speakers' Bureau (Ongoing)|Dexcom: Consultant / Advisory Board (Ongoing)|Novo Nordisk: Consultant / Advisory Board (Terminated, May 12, 2022)

Jodi Lavin-Tompkins, MSN, RN, BC-ADM, CDCES - Stock: Gilead Sciences, Regeneron Pharma (relationship has ended)
Barbara Kocurek, PharmD, BCPS, CDCES,FADCES - No financial relationships or conflicts of interest
Magon Saunders, DHSc, MS, RDN, LD - No financial relationships or conflicts of interest
Bau Tran, PA-C, PharmD, FCCP - No financial relationships or conflicts of interest
Sean Oser, MD – Consultant: Cecelia Health, Content Development: Abbott
Anna Sabino, MSW, CDCES - No financial relationships or conflicts of interest
Chelsea Hawkins, CDCES, MCHES, RDN - No financial relationships or conflicts of interest

Disclosure and Mitigation of Relevant Conflicts of Interest

All identified relevant conflicts of interest have been mitigated.

The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.

Joint Providership

None

Financial Support

None

Accreditation

In support of improving patient care, the Association of Diabetes Care & Education Specialists is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

	Accreditation Council for Pharmacy Education (ACPE) The Universal Activity Number is JA4008258-0000-23-179-H01-P. This knowledge-based activity has been approved for 0.75 contact hour(s). This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor.
	American Medical Association (AMA) Association of Diabetes Care & Education Specialists designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
	American Nurses Credentialing Center (ANCC) Association of Diabetes Care & Education Specialists designates this activity for a maximum of 0.75 ANCC contact hour(s). This activity discusses 0.50 contact hour(s) of pharmacotherapeutic content. The Association of Diabetes Care & Education Specialists is approved by the California Board of Registered Nursing, Provider Number 10977, for 0.75 contact hour(s).
	American Academy of PAs (AAPA) The Association of Diabetes Care & Education Specialists has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credit(s). Approval is valid until 8/6/25. PAs should only claim credit commensurate with the extent of their participation.

Commission on Dietetic Registration (CDR) CDR Credentialed Practitioners will receive 0.75 Continuing Professional Education unit(s) (CPEU) for completion of this activity. Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Sphere and Competency selection is at the learner’s discretion.

Successful Completion

To receive a Statement of Credit you must participate in the full activity and complete an evaluation.

Certified Diabetes Care and Education Specialists

To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers (www.cbdce.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists is on the CBDCE list of Approved Providers.

Board Certified Advanced Diabetes Management (BC-ADM)

ADCES is the administering body for the Advanced Diabetes Management credentials. Continuing education programs offered by ADCES can be used toward fulfilling BC-ADM Certification and recertification requirements.

Other Health Professionals

It is the responsibility of each participant to determine if the program meets the criteria for re-licensure or recertification for their discipline.

Pricing

Members: $29.95
Non-Members: $39.95

Volume discounts are available and will be automatically applied at check-out when the desired quantity is selected
-- Groups of 4-9: 10% off
-- Groups of 10-19: 20% off
-- Groups of 20-29: 30% off
-- Groups of 30+: 40% off

ADCES CBs and LNGs: Please contact us at [email protected] to order a recorded webinar for a group viewing.

Access Period

You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).

Originally presented on: 8/6/2023
Expiration date: 8/6/2025